Medicine Overview of Eskinase Injection
Allergic reaction, Nausea, Vomiting, Decrease in blood pressure, Injection site bleeding.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Eskinase 1.5MIU Injection works by dissolving the harmful blood clots in the blood vessels. This allows reperfusion of affected tissue, preventing tissue death and improving outcomes.
In Depth Information on Eskinase Injection
• Inform your doctor if you have a history of tuberculosis, bronchitis (inflammation of the airway passages in the lungs) or other severe lung disease, any heart or circulation problems, or infection caused by streptococcal bacteria or rheumatic fever (bacterial disease in which there is fever and inflammation of the heart, blood vessels and joints) or throat infection.• Patients who are allergic to streptokinase or any of its ingredients.
• Should not be given to patients with history of any recent internal bleeding, unusual susceptibility to bleeding, history of blood vessels disorders (e.g. weakness in an artery, excessive localized swelling of arteries) or uncontrolled high blood pressure or have any clotting disorders or are taking any drugs to prevent blood clotting.
• Should not be given to patients who have undergone a recent surgery especially of the head or spine, or recently had a stroke, serious head injury, brain tumor, tumor which increases risk of bleeding.
• Should not be given to patients with severe liver or kidney damage or inflammation of the pancreas (acute pancreatitis) or inflammation of inner and outer layers of the heart (endocarditis or pericarditis) or peptic ulceration (sores in the lining of the stomach) or heavy vaginal bleeding.
• Should not be given to pregnant women and children.
Eskinase Injection related warnings
Interaction with alcohol is unknown. Please consult your doctor.
WEIGH RISKS VS BENEFITS
Eskinase 1.5MIU Injection may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
No information is available on the use of Eskinase 1.5MIU Injection during lactation. Please consult your doctor.
Not relevant, as Eskinase 1.5MIU Injection is intended for use in hospitalised patients.
Eskinase 1.5MIU Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Eskinase 1.5MIU Injection may not be needed in these patients. Please consult your doctor.
Use of Eskinase 1.5MIU Injection is not recommended in patients with severe kidney disease.
Eskinase 1.5MIU Injection should be used with caution in patients with severe liver disease. Dose adjustment of Eskinase 1.5MIU Injection may be needed. Please consult your doctor.
If you miss a dose of Eskinase 1.5MIU Injection, please consult your doctor.
One of the following vendor pharmacies will deliver Eskinase 1.5MIU Injection: PPR, WHL, PVP, BIO, RHL, IAD, BBS, RUS, MDH, QLF, VNS, NXG, RWP, GPP, NSL, NTB, ZVP, KMC, PEN, PWN, NVL, EMB, DGN, BLE, ATP, SWP, HIP, HPC, JIV, BTM, DLP, MLC, AYM, NNH, EVP, SLN, NDP, BAP, DYG, RKS, STA, SSA, VDH, ABP, GTC, LHA, KHC, ENP, TRP, NVY, RPI, HAT, JVN, ESY, ANT, ATL, CLT, INC, PTI, GBL, LCC, 9T9, GHR, MAX, DHR, SHC, HZF, OIP, MAM, USF, BHM, SRG, SJP, GNC, MMS, UMP, WSI, MSD, RSA, RDR, TNH, DFP, PNT, AMR, DVH, SBA, RPP, ADT, MPC, PLT, OWP, QTM, JVO, SHD, HGI, RDH, PRN, HTS, DPL, EQN, SVH, BAL, ZEL, DPP, HBV, SYN, VRS, SWA, MAK, BSN, AYU, ARD, KHH, P2P, TFP, BDN, SHP, OLT, HEX, IPL, SCH, SGH, HMP, BHP, MDO, SGC, AAY, AGT, GTK, THP, FGH, RSS, PMA, AAR, TOM, RHW, HSP, RJH, JSL, BMJ, HNP, SDM, SAF, SBL, GPT, OHM